Nuechterlein Carole
- SEC CIK
- 0001665133
No open-market purchases or sales filed in the past year.
Current role at each company
- ALGS Aligos Therapeutics, Inc.Directoras of Jun 29, 2026
- TRDA Entrada Therapeutics, Inc.Directoras of Jun 6, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nuechterlein Carole as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALGS Aligos Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2023 (view filing)4:15 PM ET | Oct 25 | 2 days | Nuechterlein CaroleDirector, 10% Owner | PPurchase | +7.93M | $0.7568 | +$6.00M | +256.6%11.0M after | |
| Oct 27, 2023 (view filing)4:15 PM ET | Oct 25 | 2 days | Nuechterlein CaroleDirector, 10% Owner | PPurchase | +3.97M | $0.125 | +$495.9K | –3.97M after | Derivative |